Issue 25, 2021

Iminosugars as glycosyltransferase inhibitors

Abstract

Iminosugars are naturally occurring carbohydrate analogues known since 1967. These natural compounds and hundreds of their synthetic derivatives prepared over five decades have been mainly exploited to inhibit the glycosidases, the enzymes catalysing the glycosidic bond cleavage, in order to find new drugs for the treatment of type 2 diabetes and other diseases. However, iminosugars are also inhibitors of glycosyltransferases, the enzymes responsible for the synthesis of oligosaccharides and glycoconjugates. The selective inhibition of specific glycosyltransferases involved in cancer or bacterial infections could lead to innovative therapeutic agents. The synthesis and biological properties of all the iminosugars assayed to date as glycosyltransferase inhibitors are reviewed in the present article.

Graphical abstract: Iminosugars as glycosyltransferase inhibitors

Associated articles

Supplementary files

Article information

Article type
Review Article
Submitted
27 fev 2021
Accepted
13 apr 2021
First published
21 apr 2021

Org. Biomol. Chem., 2021,19, 5439-5475

Iminosugars as glycosyltransferase inhibitors

I. Conforti and A. Marra, Org. Biomol. Chem., 2021, 19, 5439 DOI: 10.1039/D1OB00382H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements